Healthcare Review: DexCom, Cardiovascular Systems, OraSure Technologies, BioScrip Inc, XOMA Corp Print E-mail
By Staff and Wire Reports   
Thursday, 08 August 2013 14:42
U.S. stocks rose on Thursday, snapping a three-day string of losses as positive data from around the world gave investors a reason to buy, while Tesla soared following its results. Still, stocks are down for the week, having pulled back from record levels on concerns the Federal Reserve will start to reduce its stimulus efforts this year as the economy recovers. Gains in equities have been closely tied to the Fed's stimulative policy, and many investors are concerned economic growth may lose steam without the Fed's help.

DexCom, Inc. (NASDAQ:DXCM) shares climbed 18.97% to $26.15. The company on August 7 reported its unaudited financial results as of and for the quarter ended June 30, 2013. Total second quarter 2013 revenue grew to $35.8 million, an increase of 53% from the same quarter in 2012. The Company reported a net loss of $10.1 million, or $0.14 per share for the three months ended June 30, 2013, compared to a net loss of $14.7 million, or $0.21 per share for the three months ended June 30, 2012. The net loss of $10.1 million included $9.0 million in non-cash expenses, comprised primarily of share-based compensation, depreciation, and amortization.

Cardiovascular Systems Inc. (NASDAQ:CSII) shares climbed 12.84% to $22.15 in the early hour. The company on August 7 reported financial results for its fiscal fourth quarter and year ended June 30, 2013. The company’s fourth-quarter revenues rose to $28.8 million, a 26-percent gain from $22.9 million in the fourth quarter of fiscal 2012. The company’s fiscal 2013 fourth-quarter net loss was $(6.8) million, or $(0.28) per common share, compared to $(4.6) million, or $(0.24) per common share, in the fiscal 2012 fourth quarter.

OraSure Technologies, Inc. (NASDAQ:OSUR) shares gained 14.82% to $4.88 in the morning hour. The company on August 7 announced its consolidated financial results for the second quarter and six months ended June 30, 2013. Consolidated net revenues for the second quarter of 2013 were $24.3 million, an 8% increase from the comparable quarter of 2012. Consolidated net loss for the second quarter of 2013 was $5.3 million, or $0.10 per share, which compares to a net loss of $3.6 million, or $0.07 per share, for the second quarter of 2012.

BioScrip Inc. (NASDAQ:BIOS) shares dropped 11.43% to $14.73. The company, on August 7, announced 2013 second quarter financial results. Second quarter revenue from continuing operations was $190.7 million and the net loss from continuing operations was $8.3 million, or $0.13 per diluted share. Consolidated Adjusted EBITDA for the second quarter was $12.1 million, and consolidated adjusted earnings per diluted share for the second quarter was $0.04 per diluted share.

XOMA Corp. (NASDAQ:XOMA) shares gained 13.23% to $4.60. The company, on August 7, reported its operational highlights and financial results for the quarter ended June 30, 2013. The company reported total revenues of $7.2 million in the second quarter ended June 30, 2013, compared with $9.3 million in the corresponding period of 2012. For the second quarter of 2013, XOMA had a net loss of $17.2 million (or $0.21 per share), compared with a net loss of $16.2 million (or $0.24 per share), for the second quarter of 2012.




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter